Interactions between B-Lymphocytes and Type 1 NKT Cells in Autoimmune Diabetes

REFERENCES

• Acevedo-Suárez C. A., Hulbert C., Woodward E. J., Thomas J. W. Uncoupling of anergy from developmental arrest in anti-insulin B-cells supports the development of autoimmune diabetes. J. Immunol. 2005; 174: 827–833
   PubMed Web of Science ®Google Scholar
• Akashi T., Nagafuchi S., Anzai K., Kondo S., Kitamura D., Wakana S., Ono J., Kikuchi M., Watanabee T. Direct evidence for the contribution of B-cells to progression of insulitis and development of diabetes in non-obese diabetic mice. Int. Immunol. 1997; 9: 1159–1164
   PubMed Web of Science ®Google Scholar
• Alard P., Manirarora J. N., Parnell S. A., Hudkins J. L., Clarck S. L., Kosiewicz M. M. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice. Diabetes 2006; 55: 2098–2105
   PubMed Web of Science ®Google Scholar
• Amano M., Baumgarth N., Dick M. D., Brossay L., Kronenberg M., Herzenberg L. A., Strober S. CD1 expression defines subsets of follicular and marginal zone B-cells in the spleen: β 2-microglobulin-dependent and independent forms. J. Immunol. 1998; 161: 1710–1717
   PubMed Web of Science ®Google Scholar
• Attavanavich K., Kearney J. F. Marginal zone, but not follicular B-cells, are potent activators of naïve CD4 T-cells. J. Immunol. 2004; 172: 803–811
   PubMedGoogle Scholar
• Balazs M., Martin F., Zhou T., Kearney J. Blood dendritic cells interact with splenic marginal zone B-cells to initiate T-independent immune responses. Immunity 2002; 17: 341–352
   PubMed Web of Science ®Google Scholar
• Baxter A. G., Kinder S. J., Hammond K. J. L., Scollay R., Godfrey D. I. Association between αβTCR+CD4−CD8− T-cell deficiency and IDDM in NOD mice. Diabetes 1997; 46: 572–582
   PubMed Web of Science ®Google Scholar
• Baxter A. G., Mandel T. E. Haemolytic anemia in non-obese diabetic mice. Eur. J. Immunol. 1991; 21: 2051–2055
   PubMed Web of Science ®Google Scholar
• Bernard N. F., Ertug F., Margolese H. High incidence of thyroiditis and anti-thyroid antibobies in NOD mice. Diabetes 1992; 41: 40–46
   PubMed Web of Science ®Google Scholar
• Bezbradica J. S., Stanic A. K., Matsuki N., Bour-Jordan H., Bluestone J. A., Thomas J. W., Unutmaz D., Van Kaer L., Joyce S. Distinct roles of dendritic cells and B-cells in Vα14Jα 18 natural T-cell activation in vivo. J. Immunol. 2005; 174: 4696–4705
   PubMed Web of Science ®Google Scholar
• Bonifacio E., Atkinson M., Eisenbarth G., Serreze D., Lee-Chan E., Singh B. International workshop on lessons from animal models for human Type I diabetes: Identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in non obese diabetic mice. Diabetes 2001; 50: 2451–2458
   PubMed Web of Science ®Google Scholar
• Brigl M., Brenner M. B. CD1: Antigen presentation and T-cell function. Annu. Rev. Immunol. 2004; 22: 817–890
   PubMed Web of Science ®Google Scholar
• Brodie G. M., Wallberg M., Santamaria P., Wong F. S., Green E. A. Cells promote intra-islet CD8+ cytotoxic T-lymphocyte survival to enhance Type 1 diabetes. Diabetes 2008, DOI: 10.2337/db07-1256
   PubMedGoogle Scholar
• Brodnicki T. C., O'Donnell K., Quirk F., Tarlinton D. M. Congenic non-obese diabetic mouse strains fail to confirm linkage of a marginal zone B-lymphocyte phenotype to the Idd11 locus on Chromosome 4. J. Immunol. 2006; 176: 701–702
   PubMed Web of Science ®Google Scholar
• Burdin N., Brossay L., Kronenberg K. Immunization with α -galactosylceramide polarizes CD1-reactive NK T-cells towards TH2 cytokine synthesis. Eur. J. Immunol. 1999; 29: 2014–2025
   PubMed Web of Science ®Google Scholar
• Cardell S. L. The natural killer T-lymphocyte: A player in the complex regulation of autoimmune diabetes in non-obese diabetic mice. Clin. Exp. Immunol. 2005; 143: 194–202
   Google Scholar
• Cardell S, Tangri S, Chan S, Kronenberg M, Benoist C, Mathis D. CD1-restricted CD4+ T-cells in major histocompatibility complex Class II-deficient mice. J. Exp. Med. 1995; 182: 993–1004
   PubMed Web of Science ®Google Scholar
• Carnaud C., Gombert J.-M., Donnars O., Garchon H. J., Herbelin A. Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex. J. Immunol. 2001; 166: 2404–2411
   PubMedGoogle Scholar
• Carrillo J., Puertas M. C., Alba A., Ampudia R. M., Pastor X., Planas R., Riutort N., Alonso N., Pujol-Borrell R., Santamaria P., Vives-Pi M., Verdaguer J. Islet-infiltrating B-cells in non-obese diabetic mice predominantly target nervous system elements. Diabetes 2005; 54: 69–77
   PubMedGoogle Scholar
• Chen Y. G., Choisy-Rossy C., Holl T. M., Chapman H. D., Besra G. S., Porcelli S. A., Shaffer D. J., Roopenian D., Wilson S. B., Serreze D. V. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J. Immunol. 2005; 174: 1196–1204
   PubMed Web of Science ®Google Scholar
• Chen Y. G., Driver J. P., Silveira P. A., Serreze D. V. Congenic analysis confirms genes within the Idd13 locus contributes to impaired development of invariant NKT cells in NOD mice. Immunogenetics 2007; 59: 705–712
   PubMedGoogle Scholar
• Chen Y. G., Silveira P. A., Osborne M. A., Chapman H. D., Serreze D. V. Cellular expression requirements for inhibition of Type 1 diabetes by a dominantly protective MHC haplotype. Diabetes 2007; 56: 424–430
   PubMed Web of Science ®Google Scholar
• Chiu P. P., Jevnikar A. M., Danska J. S. Genetic control of T- and B-lymphocyte activation in nonobese diabetic mice. J. Immunol. 2001; 167: 7169–7179
   PubMedGoogle Scholar
• Chiu P. P., Serreze D. V., Danska J. S. Development and function of diabetogenic T-cells in B-cell-deficient nonobese diabetic mice. Diabetes 2001; 50: 763–770
   PubMed Web of Science ®Google Scholar
• Chung B., Aoukaty A., Dutz J., Terhorst C., Tan R. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J. Immunol. 2005; 174: 3153–3157
   PubMed Web of Science ®Google Scholar
• Cinamon G., Zachariah M. A., Lam O. M., Foss F. W., Jr, Cyster J. G. Follicular shuttling of marginal zone B-cells facilitates antigen transport. Nat. Immunol. 2008; 9: 54–62
   PubMed Web of Science ®Google Scholar
• Constant S., Schweitzer N., West J., Ranney P., Bottomly K. B-Lymphocytes can be competent antigen-presenting cells for priming CD4+ T-cells to protein antigens in vivo. J. Immunol. 1995; 155: 3734–3741
   PubMed Web of Science ®Google Scholar
• Crowe N. Y., Uldrich A. P., Kyparissoudis K., Hammond K. J. L., Hayakawa Y., Sidobre S., Keating R., Kronenberg M., Smyth M. J., Godfrey D. I. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T-cells. J. Immunol. 2003; 171: 4020–4027
   PubMed Web of Science ®Google Scholar
• Dellabona P., Padovan E., Casorati M., Brockhaus M., Lanzavecchia A. An invariant Vα24-Jα Q/Vβ 11 T-cell receptor is expressed in all individuals by clonally expanded CD4−8− T-cells. J. Exp. Med. 1994; 180: 1171–1176
   PubMed Web of Science ®Google Scholar
• Dobersen M. J., Scharff J. E., Ginsberg-Fellner F., Notkins A. L. Cytotoxic autoantibodies to β cells in the serum of patients with insulin-dependent diabetes mellitus. New Engl. J. Med. 1980; 303: 1493–1498
   PubMed Web of Science ®Google Scholar
• Eisenbarth G. S., Morris M. A., Scearce R. M. Cytotoxic antibodies to cloned rat islet cells in serum of patients with diabetes mellitus. J. Clin. Invest. 1981; 67: 403–408
   PubMed Web of Science ®Google Scholar
• Esteban L. M., Tsoutsman T., Jordan M. A., Roach D., Poulton L. D., Brooks A., Naidenko O. V., Sidobre S., Godfrey D. I., Baxter A. G. Genetic control of NKT cell number maps to major diabetes and lupus loci. J. Immunol. 2003; 171: 2873–2878
   PubMedGoogle Scholar
• Falcone M., Facciotti F., Ghidoli N., Monti P., Olivieri S., Zaccagnino L., Bonifacio E., Casorati G., Sanvito F., Sarvetnick N. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in non-obese diabetic mice. J. Immunol. 2004; 172: 5908–5916
   PubMed Web of Science ®Google Scholar
• Falcone M., Lee J., Patstone G., Yeung B., Sarvetnick N. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J. Immunol. 1998; 161: 1163–1168
   PubMed Web of Science ®Google Scholar
• Feuerer M., Jiang W., Holler P. D., Satpathy A., Campbell C., Bogue M., Mathis D., Benoist C. Enhanced thymic selection of FoxP3+ regulatory T-cells in the NOD mouse model of autoimmune diabetes diabetes. Proc. Natl. Acad. Sci. USA 2007; 104: 18181–18186
   PubMed Web of Science ®Google Scholar
• Forsgren S., Andersson A., Hillorn V., Soderstrom A., Holmberg D. Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Scand. J. Immunol. 1991; 34: 445–451
   PubMed Web of Science ®Google Scholar
• Fowlkes B. J., Kruisbick A. M., Ton That H., Weston M. A., Coligan J. E., Schwartz R. H., Pardol D. M. A novel population of T-cell receptor α β bearing thymocytes which predominantly expresses a single Vα gene family. Nature 1987; 329: 251–254
   PubMed Web of Science ®Google Scholar
• Fox C. J., Danska J. S. Independent genetic regulation of T-cell and antigen-presenting cell participation in autoimmune islet inflammation. Diabetes 1998; 47: 331–338
   PubMed Web of Science ®Google Scholar
• Galli G., Nuti S., Tavarini S., Galli-Stampino L., De Lalla C., Casorati G., Dellabona P., Abrignani S. CD1d-restricted help to B-cells by human invariant natural killer T-lymphocytes. J. Exp. Med. 2003; 197: 1051–1057
   PubMed Web of Science ®Google Scholar
• Galli G., Pittoni P., Tonti E., Malzone C., Uematsu Y., Tortoli M., Maione D., Volpini G., Finco O., Nuti S., Tavarini S., Dellabona P., Rappuoli R., Casorati G., Abrignani S. Invariant NKT cells sustain specific B-cell responses and memory. Proc. Natl. Acad. Sci. USA 2007; 104: 3984–3989
   PubMed Web of Science ®Google Scholar
• Godfrey D. I., Berzins S. P. Control points in NKT cell development. Nat. Rev. Immunol. 2007; 7: 505–518
   PubMed Web of Science ®Google Scholar
• Godfrey D. I., Hammond K. J., Poulton L. D., Smyth M. J., Baxter A. G. NKT cells: Facts, functions and fallacies. Immunol. Today 2000; 21: 573–583
   PubMedGoogle Scholar
• Godfrey D. I., Kinder S. J., Silveira P., Baxter A. G. Flow cytometric study of T-cell development in NOD mice reveals a deficiency in αβ TCR+CD4−CD8− thymocytes. J. Autoimmunity 1997; 10: 279–285
   PubMed Web of Science ®Google Scholar
• Godfrey D. I., Kronenberg M. Going both ways: Immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 2004; 114: 1379–1388
   PubMed Web of Science ®Google Scholar
• Godfrey D. I., MacDonald H. R., Kronenberg M., Smyth M. J., Van Kaer L. NKT cells: What's in a name?. Nat. Rev. Immunol. 2004; 4: 231–237
   PubMed Web of Science ®Google Scholar
• Gombert J. M., Herbelin A., Tancrede-Bohin E., Dy M., Carnaud C., Bach J. F. Early quantitative and functional deficiency of NK1+-like thymocytes in the NOD mouse. Eur. J. Immunol. 1996; 26: 2989–2998
   PubMed Web of Science ®Google Scholar
• Gray D., McConnell I., Kumararatne D. S., MacLennan I. C., Humphrey J. H., Bazin H. Marginal zone B-cells express CR1 and CR2 receptors. Eur. J. Immunol. 1984; 14: 47–52
   PubMedGoogle Scholar
• Greeley S. A. W., Katsumata M., Yu L., Eisenbarth G. S., Moore D. J., Goodarzi H., Barker C. F., Naji A., Noorchasm H. Elimination of maternally-transmitted autoantibodies prevents diabetes in non-obese diabetic mice. Nat. Med. 2002; 8: 399–402
   PubMed Web of Science ®Google Scholar
• Griewank K., Borowski C., Rietdijk S., Wang N., Julien A., Wei D. G., Mamchak A. A., Terhorst C., Bendelac A. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 2007; 27: 751–762
   PubMed Web of Science ®Google Scholar
• Hammond K. J., Pellicci D. G., Poulton L. D., Naidenklo O. V., Scalzo A. A., Baxter A. G., Godfrey D. I. CD1d-restricted NKT cells: An interstrain comparison. J. Immunol. 2001; 167: 1164–1173
   PubMed Web of Science ®Google Scholar
• Hammond K. J., Poulton L. D., Palmisano L. J., Silveira P. A., Godfrey D. I., Baxter A. G. α/β -T cell receptor (TCR)+CD4−CD8− (NKT) thymocytes prevent insulin-dependent diabetes mellitus in non-obese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 1998; 187: 1047–1056
   PubMed Web of Science ®Google Scholar
• Hong S., Wilson M. T., Serizawa I., Wu L., Singh N., Naidenko O., Miura T., Haba T., Scherer D. C., Wei J., Kronenberg M., Koezuka Y., Van Kaer L. The natural killer T-cell ligand α -galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 2001; 7: 1052–1056
   PubMed Web of Science ®Google Scholar
• Hu C. Y., Rodriguez-Pinto D., Du W., Ahuja A., Henegariu O., Wong F. S., Shlomchik M. J., Wen L. Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice. J. Clin. Invest. 2007; 117: 3857–3867
   PubMed Web of Science ®Google Scholar
• Hussain S., Delovitch T. L. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B-cells is associated with increased T-cell co-stimulation and the development of insulitis. J. Immunol. 2005; 174: 680–687
   PubMedGoogle Scholar
• Inoue Y., Kaifu T., Sugahara-Tobinai A., Nakamura A., Miyazaki J., Takai T. Activating Fcγ receptors participate in the development of autoimmune diabetes in NOD mice. J. Immunol. 2007; 179: 764–774
   PubMed Web of Science ®Google Scholar
• Jarpe A., Hickman M., Anderson J., Winter W., Peck A. Flow cytometric enumeration of mononuclear cell populations infiltrating the Islets of Langerhans in pre-diabetic NOD mice: development of a model of autoimmune insulitis for Type I diabetes. Regul. Immunol. 1991; 3: 305–317
   Google Scholar
• Johnson E. A., Silveira P., Chapman H. D., Leiter E. H., Serreze D. V. Inhibition of autoimmune diabetes in non-obese diabetic mice by transgenic restoration of H2-E MHC Class II expression: Additive, but unequal, involvement of multiple APC subtypes. J. Immunol. 2001; 167: 2404–2410
   PubMed Web of Science ®Google Scholar
• Jordan M. A., Fletcher J. M., Pellicci D., Baxter A. G. Slamf1, the NKT cell control gene Nkt1. J. Immunol. 2007; 178: 1618–1627
   PubMedGoogle Scholar
• Kanatsuna T., Lernmark A., Rubenstein A. H., Steiner D. F. Block in insulin release from column-perfused pancreatic β cells induced by islet cell surface antibodies and complement. Diabetes 1981; 30: 231–234
   PubMedGoogle Scholar
• Kendall P. L., Yu G., Woodward E. J., Thomas J. W. Tertiary lymphoid structures in the pancreas promote selection of B-lymphocytes in autoimmune diabetes. J Immunol. 2007; 178: 5643–5645
   PubMed Web of Science ®Google Scholar
• Kitamura D., Rajewsky K. Targeted disruption of μ chain membrane exon causes loss of heavy-chain allelic exclusion. Nature 1992; 356: 154–156
   PubMedGoogle Scholar
• Kronenberg M., Gapin L. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2002; 2: 557–568
   PubMed Web of Science ®Google Scholar
• Kumar K. R., Li L., Yan M., Bhaskarabhatla M., Mobley A. B., Nguyen C., Mooney J. M., Schatzle J. D., Wakel E. K., Mohan C. Regulation of B-cell tolerance by the lupus susceptibility gene Ly108. Science 2006; 312: 1665–1669
   PubMed Web of Science ®Google Scholar
• Laloux V., Beaudoin L., Jeske D., Carnaud C., Lehuen A. NK T-cell-induced protection against diabetes in Vα 14-Jα 281 transgenic non-obese diabetic mice is associated with a TH2 shift circumscribed regionally to the islets and functionally to islets autoantigens. J. Immunol. 2001; 166: 3749–3756
   PubMedGoogle Scholar
• Laloux V., Beaudoin L., Ronet C., Lehuen A. Phenotypic and functional differences between NKT cells colonizing splanchic and peripheral lymph nodes. J. Immunol. 2002; 168: 3251–3258
   PubMedGoogle Scholar
• Lang G. A., Devera T. S., Lang M. L. Requirement for CD1d expression by B-cells to stimulate NKT cell enhanced antibody production. Blood 2008; 111: 2158–2162
   PubMed Web of Science ®Google Scholar
• Lang G. A., Illarionov P. A., Glatman-Freedman A., Besra G. S., Lang M. L. BCR targeting of biotin-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments. Int. Immunol. 2005; 17: 899–908
   PubMed Web of Science ®Google Scholar
• Lantz O., Bendelac A. An invariant T-cell receptor 〈 chain is used by a unique subset of major histocompatibility complex Class I-specific CD4+ and CD4−8− in mice and humans. J. Exp. Med. 1994; 180: 1097–1106
   PubMed Web of Science ®Google Scholar
• Lehuen A., Lantz O., Beaudoin L., Laloux V., Carnaud C., Bendelac A., Bach J. F., Monteiro R. C. Over-expression of natural killer T-cells protects Vα 14-Jα 281 transgenic non-obese diabetic mice against diabetes. J. Exp. Med. 1998; 188: 1831–1839
   PubMed Web of Science ®Google Scholar
• Linsen L., Somers V., Stinissen P. Immunoregulation of autoimmunity by natural killer T-cells. Hum. Immunol. 2005; 66: 1193–1202
   PubMed Web of Science ®Google Scholar
• Mariño E., Batten M., Groom J., Silveira P., Walters S., Liuwantara D., Mackay F., Grey S. Temporal depletion of B-cells, by selectively targeting BAFF, prevents diabetes in NOD mice. Tissue Antigens 2005; 66: 488
   Google Scholar
• Mariño E., Batten M., Groom J., Walters S., Liuwantara D., Mackay F., Grey S. T. Marginal-zone B-cells of non-obese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 2008; 57: 395–404
   PubMed Web of Science ®Google Scholar
• Matsuki N., Stanic A. K., Embers M. E., Van Kaer L., Morel L., Joyce S. Genetic dissection of Vα 14Jα 18 natural T-cell number and function in autoimmune-prone mice. J. Immunol. 2003; 170: 5429–5437
   PubMed Web of Science ®Google Scholar
• Mi Q. S., Ly D., Zucker P., McGarry M., Delovitch T. L. Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent Type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells. Diabetes 2004; 53: 1303–1310
   PubMed Web of Science ®Google Scholar
• Miao D., Yu L., Eisenbarth G. S. Role of autoantibodies in Type 1 diabetes. Front. Biosci. 2007; 12: 1889–1898
   PubMedGoogle Scholar
• Naumov Y. N., Bahjat K. S., Gausling R., Abraham R., Exley M. A., Koezuka Y., Balk S. B., Strominger J. L., Clare-Salzer M., Wilson S. B. Activation of CD1d-restricted T-cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 2001; 98: 13838–13843
   PubMed Web of Science ®Google Scholar
• Nichols K. E., Hom J., Gong S. Y., Ganguly A., Ma C. S., Cannons J. L., Tangye S. G., Schwartzberg P. L., Koretzky G. A., Stein P. L. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 2005; 11: 340–345
   PubMed Web of Science ®Google Scholar
• Noorchashm H., Lieu Y. K., Noorchashm N., Rostami S. Y., Greeley S. A., Schlachterman A., Song H. K., Noto L. E., Jevnikar A. M., Barker C. F., Naji A. I-Ag7-mediated antigen presentation by B-lymphocytes is critical in overcoming a checkpoint in T-cell tolerance to islet beta cells of non-obese diabetic mice. J. Immunol. 1999; 163: 743–750
   PubMed Web of Science ®Google Scholar
• Noorchashm H., Moore D. J., Lieu Y. K., Noorchashm N., Schlachterman A., Song H. K., Barker C. F., Naji A. Contribution of the innate immune system to autoimmune diabetes: A role for the CR1/CR2 complement receptors. Cell. Immunol. 1999; 195: 75–79
   PubMed Web of Science ®Google Scholar
• Noorchashm H., Noorchashm N., Kern J., Rostami S. Y., Barker C. F., Naji A. B-Cells are required for the initiation of insulitis and sialitis in non-obese diabetic mice. Diabetes 1997; 46: 941–946
   PubMed Web of Science ®Google Scholar
• Pasquier B., Yin L., Fondaneche M. C., Relouzat F., Bloch-Queyrat C., Lambert N., Fischer A., de Saint-Basile G., Latour S. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 2005; 201: 695–701
   PubMed Web of Science ®Google Scholar
• Pellicci D. G., Hammond K. J., Uldrich A. P., Baxter A. G., Smyth M. J., Godfrey D. I. A natural killer T (NKT) cell developmental pathway involving a thymus-dependent NK1.1-CD4+ CD1d- dependent precursor stage. J. Exp. Med. 2002; 195: 835–844
   PubMed Web of Science ®Google Scholar
• Porcelli S. A., Modlin R. L. The CD1 system: Antigen-presenting molecules for T-cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 1999; 17: 297–329
   PubMed Web of Science ®Google Scholar
• Poulton L. D., Smyth M. J., Hawke C. G., Silveira P., Shepherd D., Naidenko O. V., Godfrey D. I., Baxter A. G. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice. Int. Immunol. 2001; 13: 887–896
   PubMedGoogle Scholar
• Roark J. H., Park S. H., Jayawardena J., Kavita U., Shannon M., Bendelac A. CD1.1 expression by mouse antigen-presenting cells and marginal zone B-cells. J Immunol. 1998; 160: 3121–3127
   PubMed Web of Science ®Google Scholar
• Rocha-Campos A. C., Melki R., Zhu R., Deruytter N., Damotte D., Dy M., Herbelin A., Garchon H. J. Genetic and functional analysis of the Nkt1 locus using congenic NOD mice: Improved Vα 14-NKT cell performance but failure to protect against diabetes. Diabetes 2006; 55: 1163–1170
   PubMedGoogle Scholar
• Rolf J., Motta V., Duarte N., Lundholm M., Berntman E., Bergman M. L., Sorokin L., Cardell S. L., Holmberg D. The enlarged population of marginal zone/CD1dhigh B-lymphocytes in non-obese diabetic mice maps to diabetes susceptibility region Idd11. J. Immunol. 2005; 174: 4821–4827
   PubMed Web of Science ®Google Scholar
• Salomon B., Lenschow D. J., Rhee L., Ashourian N., Singh B., Sharpe A., Bluestone J. A. B7/CD28 co-stimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T-cells that control autoimmune diabetes. Immunity 2000; 12: 431–440
   PubMed Web of Science ®Google Scholar
• Savino W., Boitard C., Bach J. F., Dardenne M. Studies on the thymus in non-obese diabetic mouse: Changes in the microenvironmental compartments. Lab. Invest. 1991; 64: 405–417
   PubMedGoogle Scholar
• Serreze D. V., Chapman H. D., Varnum D. S., Hanson M. S., Reifnyder P. C., Richard S. D., Fleming S. A., Leiter E. H., Shultz L. D. B-Lymphocytes are essential for the initiation of T-cell-mediated autoimmune diabetes: Analysis of a new speed congenic stock of NOD.Igμnull mice. J. Exp. Med. 1996; 184: 2049–2053
   PubMed Web of Science ®Google Scholar
• Serreze D. V., Fleming S. A., Chapman H. D., Richard S. D., Leiter E. H., Tisch R. M. B lymphocytes are critical antigen-presenting cells for the initiation of T-cell-mediated autoimmune diabetes in non-obese diabetic mice. J. Immunol. 1998; 161: 3912–3918
   PubMed Web of Science ®Google Scholar
• Sharif S., Arreaza G. A., Zucker P., Mi Q. S., Sondhi J., Naidenko O. V., Kronenberg M., Koezuka Y., Delovitch T. L., Gombert J. M., Leite-De-Moraes M., Gouarin C., Zhu R., Hameg A., Nakayama T., Taniguchi M., Lepault F., Lehuen A, Bach J. F., Herbelin A. Activation of natural killer T-cells by α -galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 2001; 7: 1057–1062
   PubMed Web of Science ®Google Scholar
• Shi F. D., Flodstrom M., Balasa B., Kim S. H., Van Gunst K., Strominger J. L., Wilson S. B., Sarvetnick N. Germ line deletion of the CD1d locus exacerbates diabetes in the NOD mouse. Proc. Natl. Acad. Sci. USA 2001; 98: 6777–6782
   PubMed Web of Science ®Google Scholar
• Shimosaka A. Role of NKT cells and alpha-galactosyl ceramide. Int. J. Hematol. 2002; 76: 277–279
   PubMedGoogle Scholar
• Shortman K., Liu Y. J. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002; 2: 151–161
   PubMed Web of Science ®Google Scholar
• Silveira P. A., Baxter A. G. The NOD mouse as a model of SLE. Autoimmunity 2001; 34: 53–64
   PubMed Web of Science ®Google Scholar
• Silveira P. A., Chapman H. D., Stolp J., Johnson E., Cox S. L., Hunter K., Wicker L. S., Serreze D. V. Genes within the Idd5 and Idd9/11 diabetes susceptibility loci affect the pathogenic activity of B-cells in NOD mice. J. Immunol. 2006; 177: 7033–7041
   PubMed Web of Science ®Google Scholar
• Silveira P. A., Dombrowsky J., Johnson E., Chapman H. D., Nemazee D., Serreze D. V. B-Cell selection defects underlie the development of diabetogenic APC in non-obese diabetic mice. J. Immunol. 2004; 172: 5086–5094
   PubMed Web of Science ®Google Scholar
• Silveira P. A., Grey S. T. B-Cells in the spotlight: Innocent bystanders or major players in the pathogenesis of Type 1 diabetes. Trends Endocrinol. Metab. 2006; 17: 128–135
   PubMed Web of Science ®Google Scholar
• Silveira P. A., Johnson E., Chapman H. D., Bui T., Tisch R. M., Serreze D. V. The preferential ability of B-lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self antigen-specific immunoglobulin receptors. Eur. J. Immunol. 2002; 32: 3657–3666
   PubMed Web of Science ®Google Scholar
• Singh N., Hong S., Scherer D. C., Serizawa I., Burdin N., Kronenberg M., Koezuka Y., Van Kaer L. Cutting edge: Activation of NK T-cells by CD1d and α-galactosylceramide directs conventional T-cells to the acquisition of a TH2 phenotype. J. Immunol. 1999; 163: 2373–2377
   PubMed Web of Science ®Google Scholar
• Sköld M., Behar S. M. Role of CD1d-restricted NKT cells in microbial immunity. Infect. Immun. 2003; 71: 5447–5455
   PubMedGoogle Scholar
• Sköld M., Stenstrom M., Sidobre S., Hoglund P., Kronenberg M., Cardell S. MWC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T-lymphocytes directed by T-cell receptor type. Immunology 2003; 110: 313–321
   PubMed Web of Science ®Google Scholar
• Smyth M. J., Crowe N. Y., Hayakawa Y., Takeda K., Yagita H., Godfrey D. I. NKT cells - conductors of tumor immunity?. Curr. Opin. Immunol. 2002; 14: 165–171
   PubMed Web of Science ®Google Scholar
• Sonoda K. H., Stein-Streinlein J. CD1d on antigen-transporting APC and splenic marginal zone B-cells promotes NKT cell-dependent tolerance. Eur. J. Immunol. 2002; 32: 848–857
   PubMed Web of Science ®Google Scholar
• Takahashi T., Strober S. Natural killer T-cells and innate immune B-cells from lupus-prone NZB/W mice interact to generate IgM and IgG autoantibodies. Eur. J. Immunol. 2008; 38: 156–165
   PubMed Web of Science ®Google Scholar
• Tian J., Zekzer D., Lu Y., Dang H., Kaufman D. L. B-Cells are crucial for determinant spreading of T-cell autoimmunity among β cell antigens in diabetes-prone non-obese diabetic mice. J. Immunol. 2006; 176: 2654–2661
   PubMed Web of Science ®Google Scholar
• Unternaehrer J. J., Chow A., Pypaert M., Inaba K., Mellman I. The tetraspanin CD9 mediates lateral association of MHC Class II molecules on the dendritic cell surface. Proc. Natl. Acad. Sci USA 2007; 104: 234–239
   PubMedGoogle Scholar
• Vasquez A. C., Feili-Hariri M, Tan R. J., Morel P. A. Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice. Clin. Exp. Immunol. 2004; 135: 209–218
   PubMed Web of Science ®Google Scholar
• Waldschmidt T. J., Kroese F. G., Tygrett L. T., Conrad D. H., Lynch R. G. The expression of B-cell surface receptors. III. The murine low-affinity IgE Fc receptor is not expressed on Ly 1 or ‘Ly 1-like’ B-cells. Int. Immunol. 1991; 3: 305–315
   PubMed Web of Science ®Google Scholar
• Wheat W., Kupfer R., Gutches D. G., Rayat G. R., Beilke J., Scheinman R. I., Wegmann D. R. Increased NF-κ B activity in B-cells and bone marrow-derived dendritic cells from NOD mice. Eur J Immunol 2004; 34: 1395–1404
   PubMed Web of Science ®Google Scholar
• Won W. J., Kearney J. F. CD9 is a unique marker for marginal zone B-cells, B1 cells, and plasma cells in mice. J. Immunol. 2002; 168: 5605–5611
   PubMedGoogle Scholar
• Wong F. S., Visintin I., Wen L., Granata J., Flavell R., Janeway C. A. The role of lymphocyte subsets in accelerated diabetes in non-obese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice. J. Exp. Med. 1998; 187: 1985–1993
   PubMed Web of Science ®Google Scholar
• Wong F. S., Wen L. B-Cells in autoimmune diabetes. Rev. Diabetic Stud. 2005; 2: 121–135
   PubMedGoogle Scholar
• Wong S., Guerder S., Visintin I., Reich E. P., Swenson K. E., Flavell R. A., Janeway C. A. Expression of the co-stimulator molecule B7-1 in pancreatic β cells accelerates diabetes in the NOD mouse. Diabetes 1995; 44: 326–329
   PubMedGoogle Scholar
• Wu A. J., Hua H., Munson S. H., McDevitt H. O. Tumor necrosis factor-α regulation of CD4+CD25+ T-cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 2002; 99: 12287–12292
   PubMed Web of Science ®Google Scholar
• Yang M., Charlton B., Gautam A. M. Development of insulitis and diabetes in B-cell-deficient NOD mice. J. Autoimmun. 1997; 10: 257–260
   PubMed Web of Science ®Google Scholar
• Yoshimoto T., Bendelac A., Watson C., Hu-Li J., Paul W. E. Role of NK1.1+ T-cells in a TH2 response and in immunoglobin E production. Sciences 1995; 270: 1845–1847
   PubMed Web of Science ®Google Scholar
• Yu L., Eisenbarth G. S. Humoral autoimmunity. Immunology of Type I Diabetes, 2nd Edition, G. S. Eisenbarth. Landes Bioscience, Austin, TX 2004; 247–260
   Google Scholar
• Zeng D., Liu Y., Sidobre S., Kronenberg M., Strober S. Activation of natural killer T-cells in NZB/W mice induces TH1-type immune responses exacerbating lupus. J. Clin. Invest. 2005; 112: 1211–1222
   Google Scholar